New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency. 2021

David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
Ipsen Bioinnovation, 102 Park Drive, Abingdon OX14 3YS, UK.

Botulinum neurotoxins (BoNTs) are notorious toxins and powerful agents and can be lethal, causing botulism, but they are also widely used as therapeutics, particularly to treat neuromuscular disorders. As of today, the commercial BoNT treatments available are from native A or B serotypes. Serotype F has shown efficacy in a clinical trial but has scarcely been used, most likely due to its medium duration of effect. Previously, the uniqueness of the light chain of the F7 subtype was identified and reported, showing an extended interaction with its substrates, VAMPs 1, 2 and 3, and a superior catalytic activity compared to other BoNT/F subtypes. In order to more extensively study the properties of this neurotoxin, we engineered a modified F7 chimera, mrBoNT/F7-1, in which all the regions of the neurotoxin were identical to BoNT/F7 except the activation loop, which was the activation loop from BoNT/F1. Use of the activation loop from BoNT/F1 allowed easier post-translational proteolytic activation of the recombinant protein without otherwise affecting its properties. mrBoNT/F7-1 was expressed, purified and then tested in a suite of in vitro and in vivo assays. mrBoNT/F7-1 was active and showed enhanced potency in comparison to both native and recombinant BoNT/F1. Additionally, the safety profile remained comparable to BoNT/F1 despite the increased potency. This new modified recombinant toxin F7 could be further exploited to develop unique therapeutics to address unmet medical needs.

UI MeSH Term Description Entries
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010791 Phrenic Nerve The motor nerve of the diaphragm. The phrenic nerve fibers originate in the cervical spinal column (mostly C4) and travel through the cervical plexus to the diaphragm. Nerve, Phrenic,Nerves, Phrenic,Phrenic Nerves
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D002474 Cell-Free System A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p166) Cellfree System,Cell Free System,Cell-Free Systems,Cellfree Systems,System, Cell-Free,System, Cellfree,Systems, Cell-Free,Systems, Cellfree
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females

Related Publications

David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
July 2003, Vaccine,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
July 2010, Applied and environmental microbiology,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
January 1983, Toxicon : official journal of the International Society on Toxinology,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
December 2012, Alternatives to laboratory animals : ATLA,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
April 2000, Protein expression and purification,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
September 1992, FEMS microbiology letters,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
January 2003, The Journal of the American Academy of Orthopaedic Surgeons,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
March 2023, STAR protocols,
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
December 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
David Burgin, and Cindy Périer, and Gavin Hackett, and Mark Elliott, and Daniel Kwan, and Fraser Hornby, and Imran Mir, and Jacquie Maignel, and Sai Man Liu, and Matthew Beard
October 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
Copied contents to your clipboard!